ESCMID eLibrary

Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. L0010

   Favorable Response to Oral Ibrexafungerp (formerly SCY-078) in Patients with Refractory Fungal Diseases, Interim Analysis by Pathogen from a Phase 3 Open-label Study (FURI)

   Oliver A. Cornely, Cologne, Germany

   Oliver A. Cornely , Luis Ostrosky-Zeichner , Rachel Miller , Andrej Spec , George Thompson , Thomas J. Walsh , Riina Richardson , Robert Krause , Peter G. Pappas , Kathleen Mullane , Caryn G. Morse , John W. Sanders , Günter Weiss , Oliver Witzke , Jose Vazquez , Marisa H. Miceli , Thomas Patterson , Martin Hoenigl , Barbara Alexander , David Angulo Gonzalez

   16 April 2019

   Session: Recent clinical trials

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Other

2. L0007

   Therapeutic drug monitoring (TDM)-guided continuous infusion (CI) of piperacillin/tazobactam (PIP) reduces the mortality of critically ill patients in the intensive care unit (ICU)

   Daniel Christoph Richter, Heidelberg, Germany

   Daniel Christoph Richter , Otto R. Frey , Anka Roehr , Jason Roberts , Andreas Köberer , Thomas Fuchs , Thorsten Brenner , Christoph Lichtenstern , Markus A. Weigand , Alexander Brinkmann

   16 April 2019

   Session: Antimicrobial resistance and stewardship latebreakers

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Other

3. L0011

   Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of the Monoclonal Antibody Combination ASN100 for the Prevention of Staphylococcus aureus Pneumonia in Endotracheal Heavily Colo

   Zoltan Magyarics, Vienna, Austria

   Zoltan Magyarics , Karin Provost , Nimrod Adi , Tomasz Czarnik , Khatuna Japaridze , Nikoloz Kartsivadze , Mikhail Kirov , Ed Campanaro , Matthew Goodwin , Lori Muir , Marin Kollef , Chris Stevens

   16 April 2019

   Session: Recent clinical trials

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Other

4. L0012

   Exebacase (Lysin CF-301) improved clinical responder rates in methicillin resistant Staphylococcus aureus bacteremia including endocarditis compared to standard of care antibiotics alone in a first-in patient Phase 2 study

   Vance G. Fowler, Durham, United States

   Vance G. Fowler , Anita Das , Joy Lipka , Raymond Schuch , Cara Cassino

   16 April 2019

   Session: Recent clinical trials

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Other

5. L0014

   Combination antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia: the CAMERA2 randomised controlled trial

   Steven Y. C. Tong, Melbourne, Australia

   Joshua Saul Davis , Hong Foo , David Lye , Jane Nelson , Matthew O'Sullivan , David L. Paterson , Mical Paul , Archana Sud , Dafna Yahav , Steven Y. C. Tong

   16 April 2019

   Session: Recent clinical trials

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Other

6. L0013

   Efficacy and Safety Profile of Suvratoxumab, a Novel Anti-Staphylococcus aureus Monoclonal Antibody: Results of the SAATELLITE Study in Mechanically Ventilated Intensive Care Unit Patients

   Bruno François, Limoges, France

   Bruno François , Miguel Garcia Sanchez , Philippe Eggimann , Pierre-Francois Dequin , Pierre-Francois Laterre , Vincent Huberlant , Dolores Escudero , Thierry Boulain , Cédric Bretonnière , Jerome Pugin , José Trenado Álvarez , Ana Catalina Padilla , S. Omar Ali , Kathryn Shoemaker , Alexey Ruzin , Vadryn Pierre , Yuling Wu , Julie VIGNAUD , Susan Colbert , Terramika Bellamy , Filip Dubovsky , Hasan S. Jafri

   16 April 2019

   Session: Recent clinical trials

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Other

7. L0008

   Effect of direct rapid antibiotic susceptibility testing (drast) on treatment for bacteremia in patients with hematologic diseases: interim analysis of randomized controlled trial

   Wan Beom Park, Seoul, Korea, Republic of

   Jeong-Han Kim , Taek Soo Kim , June Young Chun , Seo Jun-won , Chang Kyung Kang , Kang Il Jun , Youngil Koh , Dong-Yeop Shin , Junshik Hong , Nam Joong Kim , Sung-Soo Yoon , Myoung-don Oh , Inho Kim , Wan Beom Park

   16 April 2019

   Session: Antimicrobial resistance and stewardship latebreakers

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   Abstract publication

   Other

8. 384474

   Case 3

   Synne Jenum, Oslo, Norway

   16 April 2019

   Session: Clinical Grand Rounds 2019

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   2-Hour Symposium

   Other

9. 384473

   Case 2

   Ana Verónica Halperin, Madrid, Spain

   16 April 2019

   Session: Clinical Grand Rounds 2019

   Relevance:

    

   100%

    

   

   Event: ECCMID 2019
   Amsterdam, The Netherlands
   2-Hour Symposium

   Other

10. 384472

    Case 1

    Cansu Cimen, Istanbul, Turkey

    16 April 2019

    Session: Clinical Grand Rounds 2019

    Relevance:

     

    100%

     

    

    Event: ECCMID 2019
    Amsterdam, The Netherlands
    2-Hour Symposium

    Other